Nogra Pharma
Business Services · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
33 Sir John Rogerson's Quay, Dublin, Sou...Phone Number
+44 7126870489Website
www.nographarma.comRevenue
$5.8 MillionIndustry
About Nogra Pharma
Is Nogra Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nogra Pharma launches new products
Check out if Nogra Pharma is spiking on competitors!
Earning: See what the market has to say on Nogra Pharma recently announced quarterly report
Check if Nogra Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nogra Pharma
Nogra Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nogra Pharma has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Nogra Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Nogra Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Nogra Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nogra Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nogra Pharma.
Nogra Pharma Tech Stack
A closer look at the technologies used by Nogra Pharma
Nogra Pharma News & Media
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nogra Pharma
Nogra Pharma is a Pharmaceutical and R&D Management Company specializing in the development of new therapeutic agents for Immune-Inflammatory-Mediated Diseases, progressing from target validation to Phase II Proof-of-Concept clinical studies. The company aims to establish long-term R&D partnerships with universities and research institutes to sourc... Read More